Physician profile
Danielle Laskowitz
NPI 1437696408
$2,214.03
in general payments reported to CMS, 2019-2025
12 companies · $835 in 2025
The $835 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $427 · 2022: $118 · 2023: $250 · 2024: $584 · 2025: $835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,668.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $354.42 | 2022-2025 | |
| Medtronic, INC. | $332.14 | 2024-2025 | Signia, Aquamantys(Tm) |
| Alcresta Therapeutics, INC. | $212.78 | 2024 | Relizorb |
| Astrazeneca Pharmaceuticals Lp | $209.45 | 2023-2024 | Lynparza |
| E.R. Squibb & Sons, L.L.C. | $181.69 | 2021 | |
| Boston Scientific Corporation | $173.92 | 2025 | Icefx Cryoablation System |
| Jazz Pharmaceuticals INC. | $145.40 | 2025 | |
| Foundation Medicine, INC. | $127.88 | 2021 | |
| Pfizer INC. | $124.99 | 2025 | |
| Blue Earth Diagnostics | $124.95 | 2023 | |
| Eisai INC. | $117.45 | 2021 | |
| Amgen INC. | $108.96 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Laskowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.